RBM: CHALLENGES AND OPPORTUNITIES
If you’re like most clinical operations professionals from a small- to mid-sized pharma and biopharm, what you have heard about RBM has left you with more questions than answers. Jennifer Newman is the Global Project Leader for Regulatory Affairs and Clinical Operations at Celldex Therapeutics. Jennifer's experience with RBM stems from having been part of the first team to implement RBM in a large-scale study.
Welcome to Clinical Leader Live – An interactive forum to discuss some of the most important technologies and trends impacting clinical trials.
Throughout the year, our editors sit down with industry experts to discuss how sponsor companies can tackle some of today's biggest challenges they may face in managing a clinical trial. Even better, the audience gets to ask questions during the presentation. Each Clinical Leader Live session is archived and can be accessed at any time by registered site users.